As of 2025-06-13, the Relative Valuation of Kala Pharmaceuticals Inc (KALA) is (103.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.45 USD, the upside of Kala Pharmaceuticals Inc based on Relative Valuation is -2416.6%.
The range of the Relative Valuation is (104.58) - (101.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 18.3x | 17.8x |
| Forward P/E multiples | 18.9x - 21.7x | 19.4x |
| Fair Price | (104.58) - (101.37) | (103.09) |
| Upside | -2450.1% - -2378.1% | -2416.6% |
| Date | P/E |
| 2025-06-10 | -0.82 |
| 2025-06-09 | -0.74 |
| 2025-06-06 | -0.75 |
| 2025-06-05 | -0.75 |
| 2025-06-04 | -0.75 |
| 2025-06-03 | -0.74 |
| 2025-06-02 | -0.64 |
| 2025-05-30 | -0.67 |
| 2025-05-29 | -0.69 |
| 2025-05-28 | -0.69 |
| 2025-05-27 | -0.73 |
| 2025-05-23 | -0.73 |
| 2025-05-22 | -0.74 |
| 2025-05-21 | -0.68 |
| 2025-05-20 | -0.71 |
| 2025-05-19 | -0.66 |
| 2025-05-16 | -0.66 |
| 2025-05-15 | -0.58 |
| 2025-05-14 | -0.59 |
| 2025-05-13 | -0.63 |
| 2025-05-12 | -0.63 |
| 2025-05-09 | -0.62 |
| 2025-05-08 | -0.62 |
| 2025-05-07 | -0.62 |
| 2025-05-06 | -0.62 |
| 2025-05-05 | -0.66 |
| 2025-05-02 | -0.68 |
| 2025-05-01 | -0.67 |
| 2025-04-30 | -0.72 |
| 2025-04-29 | -0.77 |
| 2025-04-28 | -0.65 |
| 2025-04-25 | -0.58 |
| 2025-04-24 | -0.60 |
| 2025-04-23 | -0.56 |
| 2025-04-22 | -0.53 |
| 2025-04-21 | -0.60 |
| 2025-04-17 | -0.63 |
| 2025-04-16 | -0.63 |
| 2025-04-15 | -0.64 |
| 2025-04-14 | -0.63 |
| 2025-04-11 | -0.61 |
| 2025-04-10 | -0.62 |
| 2025-04-09 | -0.70 |
| 2025-04-08 | -0.63 |
| 2025-04-07 | -0.68 |
| 2025-04-04 | -0.77 |
| 2025-04-03 | -0.84 |
| 2025-04-02 | -0.86 |
| 2025-04-01 | -1.04 |
| 2025-03-31 | -1.04 |